Form 4 Tracker
Harlan S Robins

Chief Scientific Officer · 8 filings · Latest: Jul 21, 2026

Adaptive Biotechnologies Corp
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
ADPT
Harlan Robins—Aug 20, 2026
Proposed Sale
$25.44402,160$10.2M—
ADPT
Harlan Robins—Aug 19, 2026
Proposed Sale
$25.49215,632$5.5M—
ADPT
Harlan Robins—Aug 18, 2026
Proposed Sale
$24.56261,044$6.4M—
ADPT
Harlan Robins—Aug 17, 2026
Proposed Sale
$24.77300,992$7.5M—
ADPT
Harlan S RobinsChief Scientific OfficerJul 21, 2026
Sale
$21.89492,400$10.8M812,058
ADPT
Harlan S RobinsChief Scientific OfficerJul 21, 2026
Option Exercise
$6.55284,800$1.9M1,304,458
ADPT
Harlan Robins—Jul 21, 2026
Proposed Sale
$22.58492,400$11.1M—
ADPT
Harlan S RobinsChief Scientific OfficerJul 2, 2026
Sale
$22.01386,240$8.5M1,019,658
ADPT
Harlan Robins—Jul 2, 2026
Proposed Sale
$21.19386,240$8.2M—
ADPT
Harlan S RobinsChief Scientific OfficerJun 16, 2026
Sale
$18.016,160$110.9K1,405,898
ADPT
Harlan S RobinsChief Scientific OfficerJun 15, 2026
Sale
$17.37100,000$1.7M1,412,058
ADPT
Harlan Robins—Jun 16, 2026
Proposed Sale
$17.226,160$106.1K—
ADPT
Harlan Robins—Jun 15, 2026
Proposed Sale
$17.46100,000$1.7M—
ADPT
Harlan S RobinsChief Scientific OfficerApr 8, 2026
Sale
$14.8510,000$148.5K1,512,058
ADPT
Harlan Robins—Apr 8, 2026
Proposed Sale
$14.8410,000$148.4K—
ADPT
ROBINS HARLAN S—Mar 11, 2026
Proposed Sale
$14.52470,266$6.8M—
ADPT
Harlan S RobinsChief Scientific OfficerMar 11, 2026
Sale
$13.17470,266$6.2M1,522,058
ADPT
Harlan S RobinsChief Scientific OfficerMar 3, 2026
Sale
$16.5214,233$235.1K1,155,291
ADPT
Harlan S RobinsChief Scientific OfficerMar 2, 2026
Sale
$15.7210,000$157.2K1,169,524
ADPT
Harlan Robins—Mar 3, 2026
Proposed Sale
$16.0814,233$228.9K—

Page 1 of 2

Next →